Christopher Steer

4.3k total citations · 1 hit paper
89 papers, 2.2k citations indexed

About

Christopher Steer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Christopher Steer has authored 89 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 22 papers in Geriatrics and Gerontology. Recurrent topics in Christopher Steer's work include Frailty in Older Adults (22 papers), Palliative Care and End-of-Life Issues (16 papers) and Ovarian cancer diagnosis and treatment (15 papers). Christopher Steer is often cited by papers focused on Frailty in Older Adults (22 papers), Palliative Care and End-of-Life Issues (16 papers) and Ovarian cancer diagnosis and treatment (15 papers). Christopher Steer collaborates with scholars based in Australia, United Kingdom and United States. Christopher Steer's co-authors include Hans Wildiers, Matti Aapro, Étienne Chatelut, Stuart M. Lichtman, Vincent Launay‐Vacher, Ravindran Kanesvaran, Martine Extermann, Arti Hurria, Gavin Marx and Desmond Yip and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Lancet Oncology.

In The Last Decade

Christopher Steer

83 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations

2014 494 citations Siri Rostoft, Christopher Steer et al. Annals of Oncology profile →

Peers

Countries citing papers authored by Christopher Steer

Since Specialization

Citations

This map shows the geographic impact of Christopher Steer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Steer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Steer more than expected).

Fields of papers citing papers by Christopher Steer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Steer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Steer. The network helps show where Christopher Steer may publish in the future.

Co-authorship network of co-authors of Christopher Steer

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Steer. A scholar is included among the top collaborators of Christopher Steer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Steer. Christopher Steer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry study 2025 ·Clinical Genitourinary Cancer ·Colin C. Williams, (unknown), Wei Hong, (unknown), A. Antón, Andrew Weickhardt, Shirley Wong, Jeremy Shapiro, Phillip Parente, Jeffrey C. Goh, Javier Torres, (unknown), Anthony M. Joshua, Stephen Brown, Christopher Steer, (unknown), Peter Gibbs, Ben Tran, Arun Azad	1
2	Adequate assessment yields appropriate care—the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group 2024 ·ESMO Open ·Kah Poh Loh, Gábor Liposits, Sankalp Arora, Nina Rosa Neuendorff, Fábio Gomes, Jessica L. Krok‐Schoen, Teresa Amaral, (unknown), Laura Biganzoli, Étienne Brain, (unknown), (unknown), Maxime Frélaut, Ravindran Kanesvaran, Anna Rachelle Mislang, D. Papamichael, Christopher Steer, Siri Rostoft	19
3	Geriatric Oncology in the Instagram Era: Feasibility and Acceptability Randomised Controlled Trial on Adopting PhotoVoice to Enable Empowerment, Patient-Centred Care, and Shared Decision Making—Study Protocol 2023 ·Methods and Protocols ·Christopher Steer, Tshepo Rasekaba, (unknown), (unknown), (unknown), (unknown), (unknown), Irene Blackberry	1
4	Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian/New Zealand modified Delphi study 2023 ·Supportive Care in Cancer ·(unknown), (unknown), Linda Brown, Cristina M. Caperchione, Katherine Clark, Andrea Cross, Phillip Good, (unknown), Tim Luckett, Jennifer Philip, Christopher Steer, Janette L. Vardy, (unknown), Meera Agar	2
5	Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation 2023 ·European Journal of Cancer ·Alison M. Weppler, Laetitia Da Meda, Inês Pires da Silva, Wen Xu, Giovanni Grignani, Alexander M. Menzies, Matteo S. Carlino, Georgina V. Long, Serigne Lo, Ina Nordman, Christopher Steer, Megan Lyle, Claudia Trojaniello, Paolo A. Ascierto, Célèste Lebbé, Shahneen Sandhu	14
6	Association between antihypertensive medicine use and risk of ovarian cancer in women aged 50 years and older 2023 ·Cancer Epidemiology ·(unknown), Katrina Spilsbury, Penelope M. Webb, Melinda M. Protani, Suzanne C. Dixon‐Suen, Sallie‐Anne Pearson, Peter Donovan, Michael Coory, Christopher Steer, Louise M. Stewart, Nirmala Pandeya, Susan J. Jordan	1
7	The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: A systematic review 2023 ·Journal of Geriatric Oncology ·(unknown), (unknown), Wee Kheng Soo, (unknown), (unknown), Christopher Steer, (unknown), (unknown), Jane Phillips, Meera Agar	23
8	Integrated care for older people with cancer: a primary care focus 2023 ·The Lancet Healthy Longevity ·Wee Kheng Soo, (unknown), Jane Crowe, Heather Lane, Christopher Steer, Pēteris Dārziņš, Ian D. Davis	7
9	Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older 2022 ·JNCI Journal of the National Cancer Institute ·(unknown), Penelope M. Webb, Melinda M. Protani, Katrina Spilsbury, Sallie‐Anne Pearson, Michael Coory, Peter Donovan, Christopher Steer, Louise M. Stewart, Nirmala Pandeya, Susan J. Jordan	9
10	Perioperative Beta-Blocker Supply and Survival in Women With Epithelial Ovarian Cancer and a History of Cardiovascular Conditions 2022 ·Journal of Clinical Oncology ·Katrina Spilsbury, (unknown), Sallie‐Anne Pearson, Michael Coory, Peter Donovan, Christopher Steer, Louise M. Stewart, Nirmala Pandeya, Susan J. Jordan	9
11	Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study 2022 ·Supportive Care in Cancer ·(unknown), (unknown), Linda Mileshkin, Richard W. Tothill, David D.L. Bowtell, Stephen Quinn, Anna DeFazio, Christos S. Karapetis, Nicholas Wilcken, Madhu Singh, Christopher Steer, Bo Gao, Mark Warren, Ian Collins, Narayan Karanth, (unknown), Penelope Schofield	4
12	Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative 2020 ·The Lancet Oncology ·Martine Extermann, Étienne Brain, Beverly Canin, Meena Cherian, Kwok‐Leung Cheung, Nienke A. de Glas, (unknown), Marije E. Hamaker, Ravindran Kanesvaran, Theodora Karnakis, Cindy Kenis, (unknown), Anita O’Donovan, Enrique Soto‐Pérez‐de‐Celis, Christopher Steer, Hans Wildiers	82
13	Older adults' preferred and perceived roles in decision-making about palliative chemotherapy, decision priorities and information preferences 2019 ·Journal of Geriatric Oncology ·(unknown), Belinda E. Kiely, Andrew Martin, Vasi Naganathan, Stephen Della‐Fiorentina, (unknown), (unknown), Christopher Steer, Hiren Mandaliya, (unknown), (unknown)	11
14	Prognostication in advanced cancer: update and directions for future research 2019 ·Supportive Care in Cancer ·David Hui, Carlos Eduardo Paiva, Egidio Del Fabbro, Christopher Steer, Jane Naberhuis, Marianne D. van de Wetering, Paz Fernández‐Ortega, Tatsuya Morita, Sang‐Yeon Suh, Éduardo Bruera, Masanori Mori	131
15	Supportive care in older adults with cancer – An update of research in 2015 2016 ·Journal of Geriatric Oncology ·Christopher Steer	15
16	Chemotherapy for Ovarian Cancer in the Older Adult 2009 ·Current Treatment Options in Oncology ·Christopher Steer	11
17	Evaluation of the Cockroft–Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients 2004 ·Annals of Oncology ·Gavin Marx, Glen M. Blake, Eleni Galani, Christopher Steer, (unknown), Kathryn Adamson, Dale L. Bailey, Peter Harper	91
18	Gastro-oesophageal complications in patients receiving cancer therapy: the role of proton pump inhibitors. 2002 ·PubMed ·Christopher Steer, Peter Harper	11
19	COLLECTING DUCT CARCINOMA OF THE KIDNEY ASSOCIATED WITH THE SICKLE CELL TRAIT 2001 ·International Journal of Clinical Practice ·Desmond Yip, Christopher Steer, (unknown), Jon van der Walt, Peter Harper	3
20	Management of small cell lung cancer 2001 ·Expert Review of Anticancer Therapy ·Desmond Yip, Christos S. Karapetis, Christopher Steer	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact